Nobuhiro Asai

2.5k total citations
159 papers, 1.6k citations indexed

About

Nobuhiro Asai is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nobuhiro Asai has authored 159 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Epidemiology, 67 papers in Infectious Diseases and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nobuhiro Asai's work include Pneumonia and Respiratory Infections (25 papers), Antimicrobial Resistance in Staphylococcus (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (18 papers). Nobuhiro Asai is often cited by papers focused on Pneumonia and Respiratory Infections (25 papers), Antimicrobial Resistance in Staphylococcus (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (18 papers). Nobuhiro Asai collaborates with scholars based in Japan, United States and Australia. Nobuhiro Asai's co-authors include Mao Hagihara, Yuka Yamagishi, Hideo Kato, Yusuke Koizumi, Hiroshige Mikamo, Daisuke Sakanashi, Hiroyuki Suematsu, Yoshihiro Ohkuni, Hiroshige Mikamo and Nicholas W. Lukacs and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Nobuhiro Asai

150 papers receiving 1.6k citations

Peers

Nobuhiro Asai
Nobuhiro Asai
Citations per year, relative to Nobuhiro Asai Nobuhiro Asai (= 1×) peers Kazufumi Hiramatsu

Countries citing papers authored by Nobuhiro Asai

Since Specialization
Citations

This map shows the geographic impact of Nobuhiro Asai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Asai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Asai more than expected).

Fields of papers citing papers by Nobuhiro Asai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Asai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Asai. The network helps show where Nobuhiro Asai may publish in the future.

Co-authorship network of co-authors of Nobuhiro Asai

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Asai. A scholar is included among the top collaborators of Nobuhiro Asai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Asai. Nobuhiro Asai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asai, Nobuhiro, Wataru Ohashi, Yuichi Shibata, et al.. (2024). A 15-Year Observational Cohort of Acute Empyema at a Single-Center in Japan. Antibiotics. 13(12). 1205–1205. 1 indexed citations
2.
Kato, Hideo, Takumi Umemura, Mao Hagihara, et al.. (2024). Development of a therapeutic drug‐monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study. British Journal of Clinical Pharmacology. 90(5). 1222–1230. 4 indexed citations
4.
Hagihara, Mao, Hideo Kato, Yuichi Shibata, et al.. (2023). Mycobiome and Mycobiome-Associated Diseases. Medical Mycology Journal. 64(3). 55–62. 3 indexed citations
5.
Shibata, Yuichi, Mao Hagihara, Nobuhiro Asai, et al.. (2023). A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid. Antibiotics. 12(2). 345–345. 1 indexed citations
6.
Môri, N., Jun Hirai, Wataru Ohashi, et al.. (2023). Derivation of clinical predictive factors (CHIEF) for first recurrent Clostridioides difficile infection. American Journal of Infection Control. 52(4). 419–423. 3 indexed citations
8.
Hirai, Jun, Daisuke Sakanashi, Yuji Kuge, et al.. (2022). Lemierre Syndrome Due to Dialister pneumosintes: A Case Report. Infection and Drug Resistance. Volume 15. 2763–2771. 6 indexed citations
9.
Kato, Hideo, Suzanne L. Parker, Jason A. Roberts, et al.. (2021). Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients. Antibiotics. 10(2). 100–100. 5 indexed citations
10.
Asai, Nobuhiro, Daisuke Sakanashi, Hiroyuki Suematsu, et al.. (2020). Observational study in a single institute in Japan: How many community-onset pneumonia patients would have Clostridioides difficile infections after treatment?. Journal of Infection and Chemotherapy. 26(10). 1104–1106. 4 indexed citations
11.
Sakanashi, Daisuke, Tomoko Ohno, Atsuko Yamada, et al.. (2019). A novel disk-based detection method with superior sensitivity for β-lactamase production in third-generation cephalosporin-resistant Enterobacteriaceae. Journal of Infection and Chemotherapy. 25(5). 330–336. 2 indexed citations
12.
Asai, Nobuhiro, Daisuke Sakanashi, Hiroyuki Suematsu, et al.. (2019). Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan. Journal of Infection and Chemotherapy. 25(8). 639–642. 6 indexed citations
13.
Asai, Nobuhiro, Daisuke Sakanashi, Hiroyuki Suematsu, et al.. (2019). Infective endocarditis caused by Cardiobacterium hominis endocarditis: A case report and review of the literature. Journal of Infection and Chemotherapy. 25(8). 626–629. 5 indexed citations
14.
Kato, Hideo, Mao Hagihara, Yuichi Shibata, et al.. (2019). Retrospective study on clinical efficacy and safety for daptomycin intermittent doses with or without loading dose in renal failure patients. Journal of Infection and Chemotherapy. 26(3). 215–224. 3 indexed citations
15.
Shibata, Yuichi, Mao Hagihara, Hideo Kato, et al.. (2019). Relationship between cytopenia and gestational age in infants and neonates treated with linezolid therapy. Journal of Infection and Chemotherapy. 26(1). 95–100. 1 indexed citations
16.
Shiota, Arufumi, Nobuhiro Asai, Yusuke Koizumi, et al.. (2019). Extended drip infusion of peripheral parental nutrition containing amino acids might be associated with Bacillus cereus bloodstream infection. American Journal of Infection Control. 47(9). 1154–1156. 4 indexed citations
17.
Shibata, Yuichi, Yuka Yamagishi, Hiroshige Mikamo, et al.. (2018). Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections. Journal of Infection and Chemotherapy. 24(9). 695–701. 9 indexed citations
18.
Nishimura, Masaki, Hiroyuki Tanaka, Nobuhiro Asai, et al.. (2017). Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion. Internal Medicine. 56(14). 1791–1797. 4 indexed citations
19.
Yamagishi, Yuka, Hiroshige Mikamo, Hideo Kato, et al.. (2017). Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model. Journal of Infection and Chemotherapy. 23(6). 368–373. 4 indexed citations
20.
Furusaki, Shintaro, Nobuhiro Asai, & Kiyochika HOSHIKAWA. (1985). Saccharification of Sweet Sorghum Bagasse by Cellulase : Presented in part at the Akita Meeting, Society of Chemical Engineers :. Journal of Fermentation Technology. 63(6). 523–528. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026